Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

225 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Low incidence of transplantation-related acute complications in patients with chronic myeloid leukemia undergoing allogeneic stem cell transplantation with a low-dose (550 cGy) total body irradiation conditioning regimen.
Khoury H, Adkins D, Brown R, Pence H, Vij R, Goodnough LT, Westervelt P, Trinkaus K, Lin HS, DiPersio Y. Khoury H, et al. Among authors: westervelt p. Biol Blood Marrow Transplant. 2001;7(6):352-8. doi: 10.1016/s1083-8791(01)80006-9. Biol Blood Marrow Transplant. 2001. PMID: 11464978 Free article. Clinical Trial.
Pharmacokinetic study of infusional valspodar.
Ma MK, McLeod HL, Westervelt P, Fracasso PM. Ma MK, et al. Among authors: westervelt p. J Clin Pharmacol. 2002 Apr;42(4):412-8. J Clin Pharmacol. 2002. PMID: 11936566
Combination decitabine, arsenic trioxide, and ascorbic acid for the treatment of myelodysplastic syndrome and acute myeloid leukemia: a phase I study.
Welch JS, Klco JM, Gao F, Procknow E, Uy GL, Stockerl-Goldstein KE, Abboud CN, Westervelt P, DiPersio JF, Hassan A, Cashen AF, Vij R. Welch JS, et al. Among authors: westervelt p. Am J Hematol. 2011 Sep;86(9):796-800. doi: 10.1002/ajh.22092. Epub 2011 Aug 3. Am J Hematol. 2011. PMID: 21815182 Free article. Clinical Trial. No abstract available.
A Phase I Study of the Safety and Feasibility of Bortezomib in Combination With G-CSF for Stem Cell Mobilization in Patients With Multiple Myeloma.
Ghobadi A, Fiala MA, Rettig M, Schroeder M, Uy GL, Stockerl-Goldstein K, Westervelt P, Vij R, DiPersio JF. Ghobadi A, et al. Among authors: westervelt p. Clin Lymphoma Myeloma Leuk. 2019 Oct;19(10):e588-e593. doi: 10.1016/j.clml.2019.04.017. Epub 2019 May 2. Clin Lymphoma Myeloma Leuk. 2019. PMID: 31358485 Free PMC article. Clinical Trial.
Low-dose (550 cGy), single-exposure total body irradiation and cyclophosphamide: consistent, durable engraftment of related-donor peripheral blood stem cells with low treatment-related mortality and fatal organ toxicity.
Blum W, Brown R, Lin HS, Zehnbauer B, Khoury H, Goodnough LT, Westervelt P, Vij R, DiPersio J, Adkins D. Blum W, et al. Among authors: westervelt p. Biol Blood Marrow Transplant. 2002;8(11):608-18. doi: 10.1053/bbmt.2002.v8.abbmt080608. Biol Blood Marrow Transplant. 2002. PMID: 12463480
Salvage therapy for acute myeloid leukemia with fludarabine, cytarabine, and idarubicin with or without gemtuzumab ozogamicin and with concurrent or sequential G-CSF.
Martin MG, Augustin KM, Uy GL, Welch JS, Hladnik L, Goyal S, Tiwari D, Monahan RS, Reichley RM, Cashen AF, Stockerl-Goldstein K, Westervelt P, Abboud CN, Dipersio JF, Vij R. Martin MG, et al. Among authors: westervelt p. Am J Hematol. 2009 Nov;84(11):733-7. doi: 10.1002/ajh.21545. Am J Hematol. 2009. PMID: 19806665 Free article.
225 results